AI Day1 LLC 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-05 5:05 pm Unchanged | 2024-08-01 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 12,929,322 13.150% | 0 (Unchanged) | Filing |
| 2023-10-20 4:01 pm Purchase | 2023-10-18 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 12,929,322 14.870% | 1,475,454 (+12.88%) | Filing |
| 2023-06-12 4:12 pm Purchase | 2023-06-09 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 11,453,868 13.190% | 769,230 (+7.20%) | Filing |
| 2022-06-21 4:44 pm Purchase | 2022-06-17 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 10,684,638 14.550% | 1,306,862 (+13.94%) | Filing |
| 2021-06-09 3:43 pm Purchase | 2021-06-01 | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 9,377,776 15.100% | 9,377,776 (New Position) | Filing |